측방유동분석법 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Lateral Flow Assay Market size is expected to reach USD 18.47 Billion in 2034 from USD 10.62 Billion (2025) growing at a CAGR of 6.34% during 2026-2034.

The global lateral flow assay market has grown rapidly due to the increasing demand for rapid diagnostic tests across healthcare settings. Lateral flow assays are widely used for point-of-care testing because they provide quick, reliable results without requiring complex laboratory infrastructure. These tests are commonly used for detecting infectious diseases, pregnancy, cardiac markers, and drug abuse. Their ease of use and cost-effectiveness make them popular in both developed and developing healthcare systems.

Several factors are driving the expansion of this market, including the rising prevalence of infectious diseases and the growing need for early disease detection. The COVID-19 pandemic significantly increased awareness and adoption of rapid testing technologies, further accelerating market growth. Additionally, advancements in diagnostic technologies and the growing demand for home-based testing solutions are encouraging manufacturers to develop more accurate and user-friendly lateral flow devices.

In the future, the lateral flow assay market is expected to expand as healthcare systems continue to prioritize rapid diagnostics and decentralized testing. Increasing investments in research and development are leading to the development of more sensitive and multiplex testing solutions. As healthcare providers seek faster and more accessible diagnostic tools, lateral flow assays will continue to play a crucial role in improving global healthcare outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Kits & Reagents
• Lateral Flow Readers
• Digital/Mobile Readers
• Benchtop Readers

By Application

• Clinical Testing
• Infectious Diseases Testing
• Cardiac Marker Testing
• Pregnancy & Fertility Testing
• Cholesterol Testing/Lipid Profile Testing
• Drugs of Abuse Testing
• Veterinary Diagnostics
• Food Safety & Environment Testing
• Drug Development & Quality Testing
• Others

By Technique

• Sandwich Assays
• Competitive Assays
• Multiplex Detection Assays

By End Use

• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care
• Pharmaceutical & Biotechnology Companies
• Others

By Test

• Lateral Flow Immunoassay
• Nucleic Acid Lateral Flow Assay

COMPANIES PROFILED

• Abbott, BioRad Laboratories Inc, Siemens Healthineers AG, bioMrieux, BD, Qiagen, QuidelOrtho Corporation, F HoffmannLa Roche, DH Life Sciences LLC, Quest Diagnostics, Qiagen NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL LATERAL FLOW ASSAY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Lateral Flow Readers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Digital/Mobile Readers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Benchtop Readers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LATERAL FLOW ASSAY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Infectious Diseases Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cardiac Marker Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pregnancy & Fertility Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Cholesterol Testing/Lipid Profile Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Drugs of Abuse Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Veterinary Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Food Safety & Environment Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Drug Development & Quality Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LATERAL FLOW ASSAY MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technique
• 6.2. Sandwich Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Competitive Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Multiplex Detection Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LATERAL FLOW ASSAY MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Home Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LATERAL FLOW ASSAY MARKET: BY TEST 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Test
• 8.2. Lateral Flow Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Nucleic Acid Lateral Flow Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL LATERAL FLOW ASSAY MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Application
  • 9.2.3 By Technique
  • 9.2.4 By End Use
  • 9.2.5 By Test
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Application
  • 9.3.3 By Technique
  • 9.3.4 By End Use
  • 9.3.5 By Test
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Application
  • 9.4.3 By Technique
  • 9.4.4 By End Use
  • 9.4.5 By Test
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Application
  • 9.5.3 By Technique
  • 9.5.4 By End Use
  • 9.5.5 By Test
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Application
  • 9.6.3 By Technique
  • 9.6.4 By End Use
  • 9.6.5 By Test
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL LATERAL FLOW ASSAY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott
  • 11.2.2 Bio-Rad Laboratories Inc
  • 11.2.3 Siemens Healthineers AG
  • 11.2.4 BioMerieux
  • 11.2.5 BD
  • 11.2.6 Qiagen
  • 11.2.7 QuidelOrtho Corporation
  • 11.2.8 F. Hoffmann-La Roche
  • 11.2.9 DH Life Sciences LLC
  • 11.2.10 Quest Diagnostics
  • 11.2.11 Qiagen N.V